| scholarly article | Q13442814 |
| P2093 | author name string | T L Whiteside | |
| A D Donnenberg | |||
| W Gooding | |||
| I Kuss | |||
| P2860 | cites work | Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 |
| Signaling defects in T lymphocytes of patients with malignancy | Q33740933 | ||
| Tumor-induced immune dysfunction | Q33740940 | ||
| Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. | Q33750104 | ||
| CD27 is required for generation and long-term maintenance of T cell immunity | Q33924191 | ||
| Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients | Q36622390 | ||
| Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses | Q36688308 | ||
| HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression | Q37359597 | ||
| Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes | Q37383034 | ||
| Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer | Q38281731 | ||
| L-Arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells. | Q40813067 | ||
| Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway | Q40945542 | ||
| Turnover of naive- and memory-phenotype T cells | Q41475935 | ||
| Restoration of T-cell homeostasis after T-cell depletion | Q41665917 | ||
| Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients | Q41672999 | ||
| Homeostasis and self-tolerance in the immune system: turning lymphocytes off. | Q41735900 | ||
| Degradation of T cell receptor (TCR)-CD3-zeta complexes after antigenic stimulation | Q42947974 | ||
| Phenotypic and functional separation of memory and effector human CD8+ T cells | Q42951823 | ||
| Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. | Q43640348 | ||
| Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans | Q46083258 | ||
| Mechanisms responsible for signaling and functional defects. | Q47807130 | ||
| Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells. | Q52025486 | ||
| In vitro responses of human CD45R0brightRA- and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells. | Q52041456 | ||
| Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. | Q52247397 | ||
| Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity | Q71118293 | ||
| Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma | Q73745131 | ||
| Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer | Q74484388 | ||
| Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance | Q74597422 | ||
| Caspase-mediated degradation of T-cell receptor zeta-chain | Q77304000 | ||
| Alterations in T cell receptor and signal transduction molecules in melanoma patients | Q77555299 | ||
| Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy | Q77557345 | ||
| Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma | Q77670022 | ||
| Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma | Q78358411 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | squamous cell carcinoma | Q681817 |
| P304 | page(s) | 223-230 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck | |
| P478 | volume | 88 |
| Q50978684 | Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway. |
| Q36759195 | Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate |
| Q36616391 | Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer |
| Q40475503 | Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma. |
| Q59477539 | Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations |
| Q39328588 | Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy |
| Q30376149 | Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy. |
| Q50533722 | Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer. |
| Q58700648 | Immune and genomic signatures in oral (head and neck) cancer |
| Q59390039 | Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix |
| Q37506015 | Inverse immunological responses induced by allergic rhinitis and head and neck squamous cell carcinoma |
| Q38172153 | Lentiviral vector-based therapy in head and neck cancer (Review) |
| Q34132958 | Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer |
| Q40393609 | Lymphocyte homeostasis and the antitumor immune response |
| Q91015172 | Prognostic significance and population dynamics of peripheral monocytes in patients with oropharyngeal squamous cell carcinoma |
| Q37049217 | Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? |
| Q53521699 | Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer. |
| Q37040545 | Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer |
| Q34475726 | T cell-tumor interaction directs the development of immunotherapies in head and neck cancer |
| Q40449498 | T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine. |
| Q33715287 | The distribution and function of human memory T cell subsets in lung cancer |
| Q37002948 | The immune signature of CD8(+)CCR7(+) T cells in the peripheral circulation associates with disease recurrence in patients with HNSCC. |
| Q34194706 | Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape |
| Q91983543 | Tumor-derived exosomes (TDEs): How to avoid the sting in the tail |
| Q38057233 | Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. |
Search more.